Application considered for immunotoxin in treatment of graft-vs-host disease.
Skolnick
A
A
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000009:adverse effects; D006086:Graft vs Host Disease / Q000628:therapy*; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D012276:Ricin / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology; D014481:United States; D014486:United States Food and Drug Administration
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; C068230:zolimomab aritox; D012276:Ricin